J&J is poised to begin a rollout of shares in its consumer healthcare business, in a major test of the IPO market that has been in the doldrums for the past year.
Edmund DeMarche is a USTimesPost U.S. News Reporter based in London. His focus is on U.S. politics and the environment. He has covered climate change extensively, as well as healthcare and crime. Edmund DeMarche joined USTimesPost in 2023 from the Daily Express and previously worked for Chemist and Druggist and the Jewish Chronicle. He is a graduate of Cambridge University. Languages: English. You can get in touch with me by emailing firstname.lastname@example.org.
June 1, 2022
2 weeks ago
July 18, 2023